J. Dai

发表

Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum

Jin Dai, Herbert Y Meltzer, H. Meltzer, 2002, Neuropsychopharmacology.

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

H. Meltzer, Mei Huang, J. Dai, 2006, Psychopharmacology.

Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease: A high potency effect of clozapine

H. Meltzer, D. Riley, J. Dai, 1995 .

AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.

H. Meltzer, D. Bonhaus, A. Prus, 2007, European journal of pharmacology.

Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex

H. Meltzer, J. Ichikawa, Mei Huang, 2006, Brain Research.

N-Desmethylclozapine, a Major Metabolite of Clozapine, Increases Cortical Acetylcholine and Dopamine Release In Vivo Via Stimulation of M1 Muscarinic Receptors

H. Meltzer, J. Ichikawa, Mei Huang, 2005, Neuropsychopharmacology.

5-HT1A and 5-HT2A receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex

H. Meltzer, J. Ichikawa, J. Dai, 2002, Brain Research.

Effect of muscarinic receptor agonists xanomeline and sabcomeline on acetylcholine and dopamine efflux in the rat brain; comparison with effects of 4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one (AC260584) and N-desmethylclozapine.

H. Meltzer, Alex S. Roseman, J. Dai, 2008, European journal of pharmacology.

SR46349-B, a 5-HT2A/2C Receptor Antagonist, Potentiates Haloperidol-induced Dopamine Release in Rat Medial Prefrontal Cortex and Nucleus Accumbens

H. Meltzer, S. Bonaccorso, J. Ichikawa, 2002, Neuropsychopharmacology.

Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

H. Meltzer, M. Maes, J. Dai, 1995, European Neuropsychopharmacology.

The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: Potentiation of risperidone-, but not haloperidol-, induced dopamine efflux

H. Meltzer, A. Prus, Mei Huang, 2007, Brain Research.

5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice.

H. Meltzer, Mei Huang, J. Dai, 2011, European journal of pharmacology.

Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonism

H. Meltzer, Young-Chul Chung, J. Ichikawa, 2004, Brain Research.

Plasma Clozapine Levels and the Treatment of L-DOPA-Induced Psychosis in Parkinson's Disease

H. Meltzer, D. Riley, J. Dai, 1995, Neuropsychopharmacology.

Asenapine Increases Dopamine, Norepinephrine, and Acetylcholine Efflux in the Rat Medial Prefrontal Cortex and Hippocampus

E. Wong, H. Meltzer, M. Shahid, 2008, Neuropsychopharmacology.

Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: Relationship to plasma cortisol concentration

H. Meltzer, K. Jayathilake, J. Dai, 2011, Psychiatry Research.

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.

Jin Dai, Herbert Y Meltzer, Zhu Li, 2004, European journal of pharmacology.

Anti-aging effects exerted by Tetramethylpyrazine enhances self-renewal and neuronal differentiation of rat bMSCs by suppressing NF-kB signaling

Li-ning Su, Hui-ping Wei, Xiaoqing Song, 2019, Bioscience reports.

Neuropharmacology and Analgesia 5-HT 2 A and 5-HT 2 C receptor stimulation are differentially involved in the cortical dopamine ef fl ux — Studied in 5-HT 2 A and 5-HT 2 C genetic mutant mice

H. Meltzer, Mei Huang, J. Dai, 2010 .

DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

H. Meltzer, J. Ichikawa, J. Dai, 2001, Brain Research.

Differential Effects of M1 and 5-Hydroxytryptamine1A Receptors on Atypical Antipsychotic Drug-Induced Dopamine Efflux in the Medial Prefrontal Cortex

H. Meltzer, A. Prus, J. Dai, 2009, Journal of Pharmacology and Experimental Therapeutics.

Differential Effects of M 1 and 5-Hydroxytryptamine 1 A Receptors on Atypical Antipsychotic Drug-Induced Dopamine Efflux in the Medial Prefrontal Cortex

H. Meltzer, A. Prus, J. Dai, 2009 .

Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism

H. Meltzer, J. Ichikawa, J. Dai, 2002, Brain Research.

Acetylcholinesterase Inhibitors Are Neither Necessary nor Desirable for Microdialysis Studies of Brain Acetylcholine

H. Meltzer, J. Ichikawa, J. Dai, 2000 .

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

H. Meltzer, A. Prus, J. Ichikawa, 2005, Psychopharmacology.

Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

H. Meltzer, Young-Chul Chung, J. Ichikawa, 2002, Brain Research.

Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: Role of 5-HT1A receptor agonism

H. Meltzer, J. Ichikawa, J. Dai, 2005, Brain Research.

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.

H. Meltzer, J. Ichikawa, J. Dai, 1998, European journal of pharmacology.

5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.

H. Meltzer, J. Ichikawa, J. Dai, 2002, Brain research.

Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release

H. Meltzer, Young-Chul Chung, J. Ichikawa, 2005, Brain Research.

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex

H. Meltzer, J. Ichikawa, J. Dai, 1996, Brain Research.

R(+)-8-OH-DPAT, a selective 5-HT1A receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex

H. Meltzer, J. Ichikawa, J. Dai, 2000, Brain Research.